Latanoprost

Half-Life (t½)
TD: 4h
Formula
C26H40O5
Molecular Weight
432.59 g/mol
PubChem CID
5311221
Aliases
Xalatan

Pharmacological Mechanism

Prostaglandin F2α analog (FP receptor agonist) — increases uveoscleral aqueous humor outflow → lowers intraocular pressure. First-line topical for open-angle glaucoma. Iris pigmentation darkening + eyelash growth (used off-label for cosmetic eyelashes — bimatoprost is the FDA-approved version).

Half-Life & Elimination Curve (TD: 4h)

100%50%25%12.5%0%0h0×t½4h1×t½8h2×t½12h3×t½16h4×t½20h5×t½0×t½ (0h): 100% remaining1×t½ (4h): 50% remaining2×t½ (8h): 25% remaining3×t½ (12h): 12.5% remaining4×t½ (16h): 6.3% remaining5×t½ (20h): 3.1% remaining
Elimination (TD)
  • 0×t½0h100%
  • 1×t½4h50%
  • 2×t½8h25%
  • 3×t½12h12.5%
  • 4×t½16h6.3%
  • 5×t½20h3.1%
Elimination t½4h (TD)
Rate Constant (ke)0.173 h⁻¹
97% Washout (5×t½)20h

Dosing Guidelines

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers